This is the largest acquisition by Mankind Pharma, India’s 4th largest pharma company by market share. A formal announcement regarding the ...

Mankind Pharma, the fourth-largest pharmaceutical company in India, led by Rajeev Juneja, is seeking mergers, acquisitions, and in-licensin...

JB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen i...

Mankind Pharma, a domestic-focused Indian pharmaceutical company is looking for selective acquisition opportunities that add value to its p...

In 95, our turnover was Rs 5 crore and every year, the thought was, whatever we are doing in one year, can we do in one month? On this phil...

As part of this arrangement, Mankind Pharma is retaining Panacea's sales and marketing team engaged in the particular business.

Both the entities have entered into definitive agreements for the transaction involving a total consideration of Rs 1,872 crore. Panacea Bi...

The government’s proposal to pick up the tab for the waiver of 'interest on interest' on loans of up to Rs 2 crore clears the uncertainty o...

The 224 bed Gurgaon Hospital has been set up through Panacea Biotec's subsidiary NewRise Healthcare Private Limited in which the company ho...

BJP government has come under attack from RSS affiliated workers' body which charged it with being on "wrong track" on the economic and lab...

The world's largest steel maker ArcelorMittal is understood to be jointly working with its domestic partner Uttam Galva for setting up a Rs...

High net worth individual (HNI) and race-horse enthusiast Cyrus Poonawalla has raised his equity stake marginally in Chennai-based drugmake...

The relief rally on Dalal Street may resume Wednesday as the global markets were back in action after an unexpected rebound in homebuilding...

Vaccine maker Panacea Biotec has agreed to buy 19.9% in US-based PharmAthene for $13.1 mn.

Panacea Biotec is learnt to have bagged a $35-million drug supply order from UNICEF to supply pentavalent vaccines, the first Indian compan...

Buoyed by overseas acquisitions, the Indian pharma sector has posted a good set of numbers for the third quarter ended December 31, 2006.

Bangalore-based biopharma company Biozeen, a division of Bangalore Biotech Labs, has announced plans to set up its consulting services in P...